share_log

iBio Inc | 8-K: Current report

iBio Inc | 8-K:重大事件

美股SEC公告 ·  01/19 13:00

牛牛AI助理已提取核心訊息

On January 16, 2024, iBio Inc, a Delaware-incorporated company, entered into a material definitive agreement with Loeb Term Solutions LLC for a term loan or equipment line of credit loan amounting to $1,071,572. The loan, which bears interest at the Prime Rate plus 8.5%, was issued with proceeds of $1,027,455.23 after deducting origination and other fees. The agreement stipulates monthly payments over four years with a balloon payment due on the two-year anniversary. iBio Inc granted the lender a security interest in most of its assets, excluding intellectual property related to filed patents. The agreement allows for additional loan advances under certain conditions and defines eligible equipment for the loan. Furthermore, the company's obligations are secured by a validity guarantee from Dr. Martin Brenner and Felipe Duran, indemnifying the lender against losses due to misrepresentation or negligence by the company. The agreement includes standard events of default, with an increased interest rate applicable upon default. The full text of the agreements is attached to the report as exhibits.
On January 16, 2024, iBio Inc, a Delaware-incorporated company, entered into a material definitive agreement with Loeb Term Solutions LLC for a term loan or equipment line of credit loan amounting to $1,071,572. The loan, which bears interest at the Prime Rate plus 8.5%, was issued with proceeds of $1,027,455.23 after deducting origination and other fees. The agreement stipulates monthly payments over four years with a balloon payment due on the two-year anniversary. iBio Inc granted the lender a security interest in most of its assets, excluding intellectual property related to filed patents. The agreement allows for additional loan advances under certain conditions and defines eligible equipment for the loan. Furthermore, the company's obligations are secured by a validity guarantee from Dr. Martin Brenner and Felipe Duran, indemnifying the lender against losses due to misrepresentation or negligence by the company. The agreement includes standard events of default, with an increased interest rate applicable upon default. The full text of the agreements is attached to the report as exhibits.
2024年1月16日,特拉華州註冊成立的公司iBio Inc與Loeb Term Solutions LLC簽訂了金額爲1,071,572美元的定期貸款或設備信貸額度貸款的實質性最終協議。這筆貸款按最優惠利率加上8.5%的利息,在扣除發放費用和其他費用後,發行的收益爲1,027,455.23美元。該協議規定在四年內按月付款,並在兩週年紀念日當天付款。iBio Inc授予貸款人大部分資產的擔保權益,不包括與申請專利相關的知識產權。該協議允許在某些條件下提供額外的貸款預付款,並定義了符合貸款條件的設備。此外,該公司的債務由馬丁·布倫納博士和費利佩·杜蘭的有效性擔保保障,以補償貸款人因公司的虛假陳述或疏忽而造成的損失。該協議包括標準違約事件,違約時適用更高的利率。協議全文作爲證物附在報告中。
2024年1月16日,特拉華州註冊成立的公司iBio Inc與Loeb Term Solutions LLC簽訂了金額爲1,071,572美元的定期貸款或設備信貸額度貸款的實質性最終協議。這筆貸款按最優惠利率加上8.5%的利息,在扣除發放費用和其他費用後,發行的收益爲1,027,455.23美元。該協議規定在四年內按月付款,並在兩週年紀念日當天付款。iBio Inc授予貸款人大部分資產的擔保權益,不包括與申請專利相關的知識產權。該協議允許在某些條件下提供額外的貸款預付款,並定義了符合貸款條件的設備。此外,該公司的債務由馬丁·布倫納博士和費利佩·杜蘭的有效性擔保保障,以補償貸款人因公司的虛假陳述或疏忽而造成的損失。該協議包括標準違約事件,違約時適用更高的利率。協議全文作爲證物附在報告中。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。